Author: Selina McKee

A government-funded survey suggests that GP job satisfaction following the introduction of the current GMS contract is actually on the rise, contrary to claims that morale is at an all-time low.

Silence Therapeutics’ chairman Iain Ross has sent out letters to the company’s shareholders to address snowballing concern over the state of its battered stock, which has dropped close to 50% in value over the past six months.

Ardana’s flagship product Teverelix LA has moved a step closer to Phase II testing, following a successful meeting with US regulators during which a development path for the drug as a treatment for endometriosis was agreed upon.

London-based ImmuPharma has taken on board worldwide development and commercialisation rights to a new cancer candidate with anti-angiongenic and anti-proliferative properties.

After announcing dribs and drabs of new measures designed to tighten infection control in hospitals over recent months, the government has now laid out a full battle plan that it hopes will substantially reign in the spread of diseases such as MRSA.